[1] Aniskevich S, Leone BJ, Brull SJ. Sugammadex:a novel approach to reversal of neuromuscular blockade[J]. Expert Rev Neurother, 2011,11(2):185.
[2] Lee C. Goodbye suxamethonium[J]. Anaesthesia, 2009,64(Suppl. 1):73.
[3] Schultz P, Ibsen M, φstergaard D, et al. Onset and duration of action of rocuronium-from tracheal intubation, through intense block to complete recovery[J]. Acta Anaesthesiol Scand, 2001,45(5):612.
[4] Kopman AF, Zhaku B, Lai KS. The "intubating dose" of succinylcholine:the effect of decreasing doses on recovery time[J]. Anesthesiology, 2003,99(5):1050.
[5] Perry JJ, Lee JS, Sillberg VA, et al. Rocuronium versus succinylcholine for rapid sequence induction intubation[J]. Cochrane Database Syst Rev, 2008,2:CD002788.
[6] McTernan CN, Rapeport DA, Ledowski T. Successful use of rocuronium and sugammadex in an anticipated difficult airway scenario[J]. Anaesth Intensive Care,2010,38(2):390.
[7] 闻大翔,欧阳葆怡,杭燕南. 肌肉松弛药[M]. 上海:世界图书出版公司,2007:1.
[8] Jones RK, Caldwell JE, Brull SJ, et al. Reversal of profound rocuronium induced blockade with sugammadex:a randomized comparison with neostigmine[J].Anesthesiology,2008, 109(5):816.
[9] Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia[J]. Anesthesiology, 2010,112(4):1013.
[10] McDonnell NJ, Pavy TJ, Green LK. Sugammadex in the management of rocuronium-induced anaphylaxis[J]. Br J Anaesth, 2011,106(2):199.
[11] Plaud B, Meretoja O, Hofmockel R, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients[J]. Anesthesiology, 2009, 110(2):284.
[12] Suzuki T, Kitajima O, Ueda K, et al. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients[J]. Br J Anaesth, 2011,106(6):823.
[13] Monk T. Obesity has no clinically relevant impact upon recovery time following administration of sugammadex[C]. Presented at Annual Meeting of American Society of Anesthesiologists. Orlando:2008. Abstract A682.
[14] Desforges JC, McDonnell NJ. Sugammadex in the management of a failed intubation in a morbidly obese patient[J]. Anaesth Intensive Care, 2011,39(4):763.
[15] Van Lancker P, Dillemans B, Bogaert T, et al. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients[J]. Anaesthesia, 2011,66(8):721.
[16] Sharp LM, Levy DM. Rapid sequence induction in obstetrics revisited[J]. Curr Opin Anaesthesiol, 2009,22(3):357
[17] Puhringer FK, Kristen P, Rex C. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients:a series of seven cases[J]. Br J Anaesth, 2010, 105(5):657.
[18] Williamson RM, Mallaiah S, Barclay P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia[J]. Acta Anaesthesiol Scand, 2011, 55:694.
[19] Robertson EN, Driessen JJ, Booij LH. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure[J]. Eur J Anaesthesiol, 2005,22(1):4.
[20] Yentis SM. Suxamethonium and hyperkalaemia[J]. Anaesth Intensive Care, 1990, 18(1):92.
[21] Staals LM, Snoeck MM, Driessen JJ, et al. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function[J]. Br J Anaesth, 2008,101(4):492.
[22] Porter MV, Paleologos MS. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal[J]. Anaesth Intensive Care, 2011, 39(2):299.
[23] Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis[J]. Anaesthesia, 2010, 65(3):302.
[24] Matsuki Y, Hirose M, Tabata M, et al. The use of sugammadex in a patient with myotonic dystrophy[J].Eur J Anaesthesiol,2010,28(2):145.
[25] de Boer HD, van Esmond J, Booij LH, et al. Reversal of rocuronium induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy[J]. Paediatr Anaesth, 2009, 19(12):1226
[26] Cammu G, De Kam PJ, Demeyer I, et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers[J]. Br J Anaesth, 2008, 100(3):373
[27] de Kam PJ, van Kuijk J, Prohn M, et al. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuroniumor vecuroniumon QTc prolongation:a thorough QTc study[J]. Clin Drug Investig, 2010, 30(9):599.
[28] Peeters PA, Michiel W,Heuvel VD, et al. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects:a randomized,double-blind, crossover, placebo-controlled, single-centre study[J]. Clin Drug Investig, 2010, 30(12):867.
[29] Menendez-Ozcoidi L, Ortiz-Gómez JR. Olaguibel-Ribero JM, et al. Allergy to low dose sugammadex[J]. Anaesthesia, 2011, 66(3), 217.
[30] Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block:a systematic review and economic evaluation[J]. Br J Anaesth, 2010, 105(5):558.